Publications by authors named "Mitra Boolell"

Claim this Profile
M
Major adverse cardiovascular events risk in menopausal women treated with oral estradiol/micronized progesterone versus conjugated estrogens/medroxyprogesterone: a claims data analysis in the USA.
John C Stevenson, Rodney Baber, Risa Kagan, Rossella E Nappi, Santiago Palacios, Mitra Boolell

Climacteric· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pain Reduction in Linzagolix-Treated Patients With Uterine Fibroids: A Secondary Mediation Analysis of the PRIMROSE 1 and 2 Phase 3 Trials.
Sven Becker, Marie-Madeleine Dolmans, Francisco Carmona Herrera, Felice Petraglia, Stefan P Renner, Mitra Boolell

BJOG· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linzagolix rapidly reduces heavy menstrual bleeding in women with uterine fibroids: an analysis of the PRIMROSE 1 and 2 trials.
Jacques Donnez, Christian M Becker, Mandy Mangler, Maciej Paszkowski, Tomasz Paszkowski, Mitra Boolell

Fertil Steril· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development, content validation and feasibility of a decision aid tool for the treatment of women with menopausal symptoms.
Petra Stute, Małgorzata Bińkowska, Paula Briggs, Santiago Palacios, Linda Abetz-Webb, Mitra Boolell

Maturitas· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linzagolix therapy versus a placebo in patients with endometriosis-associated pain: a prospective, randomized, double-blind, Phase 3 study (EDELWEISS 3).
Jacques Donnez, Christian Becker, Hugh Taylor, Francisco Carmona Herrera, Olivier Donnez, Mitra Boolell

Hum Reprod· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A review of the pharmacology, clinical outcomes, and real-world effectiveness, safety, and non-contraceptive effects of NOMAC/E2.
Franca Fruzzetti, Rogerio Bonassi Machado, Iñaki Lete, Amisha Patel, Mitra Boolell

Eur J Obstet Gynecol Reprod Biol X· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is the multinational, surveillance PRO-E2 study informative for all countries? The Italian data on VTE and contraceptive effectiveness.
Franca Fruzzetti, Angelo Cagnacci, Mitra Boolell, Costantino Di Carlo, Vincenzina Bruni

Eur J Contracept Reprod Health Care· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of weekly gastro-resistant risedronate 35 mg, compared with weekly alendronate 70 mg tablets, in the treatment of postmenopausal osteoporosis in Spain.
Enrique Casado, José Rosas, Carlos Rubio-Terrés, Darío Rubio-Rodríguez, Mitra Boolell

J Comp Eff Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral estradiol/micronized progesterone may be associated with lower risk of venous thromboembolism compared with conjugated equine estrogens/medroxyprogesterone acetate in real-world practice.
Nick Panay, Rossella E Nappi, Petra Stute, Santiago Palacios, Tomasz Paszkowski, Mitra Boolell

Maturitas· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fracture risk in women with osteoporosis initiated on gastro-resistant risedronate versus immediate release risedronate or alendronate: a claims data analysis in the USA.
John A Eisman, Bernard Cortet, Mitra Boolell, Raluca Ionescu-Ittu, Francis Vekeman

Osteoporos Int· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fracture rates and economic outcomes in patients with osteoporosis prescribed risedronate gastro-resistant versus other oral bisphosphonates: a claims data analysis.
Friederike Thomasius, Santiago Palacios, Asif Alam, Mitra Boolell, Francis Vekeman

Osteoporos Int· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling and simulation of sexual activity daily diary data of patients with female sexual arousal disorder treated with sildenafil citrate (Viagra).
Laurent Claret, Eugene H Cox, Lynn McFadyen, Alwyn Pidgen, Patrick J Johnson, Mitra Boolell

Pharm Res· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a questionnaire on sexual quality of life in women.
Tara Symonds, Mitra Boolell, Frances Quirk

J Sex Marital Ther· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of sildenafil citrate (Viagra) in men with premature ejaculation.
Chris G McMahon, Bronwyn G A Stuckey, Morten Andersen, Kenneth Purvis, Nandan Koppiker, Mitra Boolell

J Sex Med· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a sexual function questionnaire for clinical trials of female sexual dysfunction.
Frances H Quirk, Julia R Heiman, Raymond C Rosen, Ellen Laan, Michael D Smith, Mitra Boolell

J Womens Health Gend Based Med· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis